As biotech gravitates to machine learning and AI, insitro's founder shares her experience of working this way since 2018

blonca9
Feb 21, 2024
1 min read

Daphne Koller describes the platform insitro has been building since it was founded in 2018, explains how she thinks the company is differentiated, and provides an update on the company's progress.

Recent Posts

See All

RBC Global Healthcare Conference: Desk Strategist Chris McCarthy shares how institutional investors have been affected by policy and macro factors, and how they have been positioning around catalysts

RBC Global Healthcare Conference: Senior Biotech Analyst Luca Issi shares his thoughts on the current state of gene and cell therapy

RBC Global Healthcare Conference: RBC's Brian Abrahams shares his take on biotech and offers advice for companies on how to navigate these times of change

As biotech gravitates to machine learning and AI, insitro's founder shares her experience of working this way since 2018

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight